Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial

Fig. 3

Survival analysis. a Kaplan–Meier survival curves of progression-free survival (PFS) per mRECIST. b Kaplan–Meier curves of overall survival. c Kaplan–Meier curves of liver-specific PFS per mRECIST. d Kaplan–Meier curves of liver-specific PFS per RECIST 1.1

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us